Caitlin Perry, MPH, is currently the Associate Director of Due Diligence Lead at Ipsen, where they spearhead high-impact initiatives. Previously, Caitlin served as a Senior Portfolio Manager in the Biosimilars Business Unit at Biogen from 2021 to 2023, managing project portfolios and financial forecasting. With a robust background that includes roles at organizations like Dana-Farber Cancer Institute and Partners HealthCare, Caitlin has demonstrated expertise in analytics, project management, and strategic planning. Caitlin earned a Master of Public Health in Biostatistics from Boston University and a Bachelor of Science in Biochemistry from the University of New Hampshire.
Location
Boston, United States
This person is not in any teams
This person is not in any offices